文献速递泌尿生殖与妇科肿瘤放疗

ESGO/ESTRO宫颈癌放射治疗质量指标

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
PubMed 文献 · Radiother Oncol · 2023-01-01

欧洲妇科肿瘤学会(ESGO)与欧洲放射肿瘤学会(ESTRO)基于科学证据和专家共识,通过系统文献检索、国际专家共识会议、内部验证及99名临床医生外部评审,制定了19项宫颈癌放射治疗结构、过程和结果质量指标,用于审计和改进临床实践。

要点

  • 每项指标含描述、可测量性规格和目标值,用于量化审计和改进。
  • 该指标集旨在标准化宫颈癌放射治疗质量,未来将与手术指标结合用于ESGO认证。

核心结论

  • 这套质量指标是标准化宫颈癌放射治疗质量的重要工具。
  • 未来将在ESGO认证过程中开发结合手术和放射治疗质量指标的评分系统,以支持机构和政府质量保证项目。

研究设计与样本

  • 质量指标基于科学证据和/或专家共识制定。
  • 制定过程包括系统文献检索以识别潜在质量指标并记录科学证据、国际专家组共识会议、内部验证过程,以及由99名临床医生组成的大型国际专家组外部评审。

主要发现

  • 共定义19项结构、过程和结果指标。
  • 质量指标1-6为一般要求,涉及治疗前检查、治疗时间、 upfront放射治疗和整体管理,包括积极参与临床研究和结构化多学科团队内的决策过程。
  • 质量指标7-17为治疗相关指标。
  • 质量指标18和19为患者结果相关指标。

关键数值与推荐

  • 每项质量指标采用结构化格式,包含描述指标测量内容的说明。
  • 详细规定可测量性规格,以定义实践中如何测量质量指标。
  • 定义目标值,以明确每个单位或中心应努力达到的水平。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Society of Gynaecological Oncology (ESGO) has previously defined and established a list of quality indicators for the surgical treatment of cervical cancer. As a continuation of this effort to improve overall quality of care for cervical cancer patients across all aspects, ESGO and the European SocieTy for Radiotherapy and Oncology (ESTRO) initiated the development of quality indicators for radiation therapy of cervical cancer. OBJECTIVE: To develop a list of quality indicators for radiation therapy of cervical cancer that can be used to audit and improve clinical practice by giving to practitioners and administrators a quantitative basis to improve care and organizational processes, notably for recognition of the increased complexity of modern external radiotherapy and brachytherapy techniques. METHODS: Quality indicators were based on scientific evidence and/or expert consensus. The development process included a systematic literature search for identification of potential quality indicators and documentation of scientific evidence, consensus meetings of a group of international experts, an internal validation process, and external review by a large international panel of clinicians (n = 99). RESULTS: Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are detailed to define how the quality indicators will be measured in practice. Targets were also defined for specifying the level which each unit or center should be aiming to achieve. Nineteen structural, process, and outcome indicators were defined. Quality indicators 1-6 are general requirements related to pretreatment workup, time to treatment, upfront radiation therapy, and overall management, including active participation in clinical research and the decision making process within a structured multidisciplinary team. Quality indicators 7-17 are related to treatment indicators. Quality indicators 18 and 19 are related to patient outcomes. DISCUSSION: This set of quality indicators is a major instrument to standardize the quality of radiation therapy in cervical cancer. A scoring system combining surgical and radiotherapeutic quality indicators will be developed within an envisaged future ESGO accreditation process for the overall management of cervical cancer, in an effort to support institutional and governmental quality assurance programs.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chargari C, Tanderup K, Planchamp F, et al. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer. Radiother Oncol. 2023. PMID: 37268359. doi:10.1016/j.radonc.2023.109589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。